Methodological issues in clinical trials of antidepressant medications: Perspectives from psychotherapy outcome research

被引:32
作者
Gaudiano, BA
Herbert, JD
机构
[1] Butler Hosp, Psychosocial Res Program, Providence, RI 02906 USA
[2] Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA
[3] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA
关键词
antidepressants/active placebos; psychotherapy; outcome research; psychotherapy outcome research; depression; randomized controlled trials;
D O I
10.1159/000082022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Despite their widespread use, the specific efficacy of antidepressant medications has been a source of debate in recent years. Examination of the literature reveals that a significant proportion of the benefit produced in antidepressant trials is duplicated in pill placebo conditions. Furthermore, early trials utilizing active placebos, or medications that mimic the common side effects of antidepressants, showed even smaller differences as compared with active medications. We examine issues surrounding the use of placebo control conditions in antidepressant trials, including the pros and cons of active placebos. We conclude that similar challenges are faced by psychotherapy outcome researchers who have focused more on the separation of specific from nonspecific treatment factors and on the effects of researcher allegiance and patient expectancy on outcome. Within this context, recommendations for improving future antidepressant research are discussed. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 69 条
[11]  
Davidson JRT, 2002, JAMA-J AM MED ASSOC, V287, P1807, DOI 10.1001/jama.287.14.1807
[12]  
*DEP HLTH, 1998, PRESCR COST AN 1997
[13]   UNBLINDING IN TRIALS OF THE WITHDRAWAL OF ANTICHOLINERGIC AGENTS IN PATIENTS MAINTAINED ON NEUROLEPTICS [J].
DOUBLE, DB .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1995, 183 (09) :599-602
[14]   Critical approach to antidepressant trials - Blindness protection is necessary, feasible and measurable [J].
Even, C ;
Siobud-Dorocant, E ;
Dardennes, RM .
BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 :47-51
[15]   Conflict of interest in psychopharmacology: Can Dr. Jekyll still control Mr. Hyde? [J].
Fava, GA .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2004, 73 (01) :1-4
[16]   The problem of the placebo response in clinical trials for psychiatric disorders: Culprits, possible remedies, and a novel study design approach [J].
Fava, M ;
Evins, AE ;
Dorer, DJ ;
Schoenfeld, DA .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2003, 72 (03) :115-127
[17]  
GAUDIANO BA, 2003, SCI REV MENT HLTH PR, V2, P74
[18]   A METAANALYSIS OF ANTIDEPRESSANT OUTCOME UNDER BLINDER CONDITIONS [J].
GREENBERG, RP ;
BORNSTEIN, RF ;
GREENBERG, MD ;
FISHER, S .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1992, 60 (05) :664-669
[19]  
GREENBERG RP, 1989, LIMITS BIOL TREATMEN, P1
[20]  
Haynes S. N., 2000, APPL CLIN P